ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 64 filers reported holding ALPINE IMMUNE SCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $760,796 | +32.7% | 66,445 | +19.1% | 0.00% | – |
| Q2 2023 | $573,367 | +140.7% | 55,775 | +80.8% | 0.00% | – |
| Q1 2023 | $238,216 | +6.3% | 30,857 | +1.2% | 0.00% | – |
| Q4 2022 | $224,094 | +30.3% | 30,489 | +27.4% | 0.00% | – |
| Q3 2022 | $172,000 | -52.9% | 23,939 | -44.2% | 0.00% | – |
| Q2 2022 | $365,000 | +78.0% | 42,916 | +87.8% | 0.00% | – |
| Q1 2022 | $205,000 | +10.8% | 22,850 | +70.8% | 0.00% | – |
| Q4 2021 | $185,000 | +65.2% | 13,379 | +26.5% | 0.00% | – |
| Q1 2021 | $112,000 | – | 10,577 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $17,640,000 | 4.25% |
| BVF INC/IL | 1,201,717 | $8,244,000 | 0.92% |
| Orbimed Advisors | 3,670,955 | $25,183,000 | 0.39% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $945,000 | 0.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 475,450 | $3,262,000 | 0.12% |
| Hikari Power Ltd | 122,972 | $844,000 | 0.09% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 15,000 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 35,750 | $245,000 | 0.00% |
| DRW Securities, LLC | 10,000 | $69,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 134,542 | $923,000 | 0.00% |